Can stem cells be used to slow diabetic kidney disease?
An exciting new clinical trial was announced in October 2015 to investigate the effectiveness of stem cells to slow the progression of diabetic kidney disease (DKD)
We take some time to talk to our in-house expert; Osam Shaikh, to learn more about this progressive new trial.
Sadly, diabetes is the most common cause of end-stage kidney disease, which often results in the need for dialysis or transplantation.
This new clinical trial, sponsored by the NHS, plans to recruit 48 patients with Type 2 diabetes. This trial will be conducted at sites including the University Hospitals Birmingham NHS Foundation Trust and Belfast Health and Social Care Trust.
It is hoped that stem cells may have the potential to limit kidney damage by reducing inflammation in the kidney. Professor Timothy O’Brien, the project leader and director of the Regenerative Medicine Institute at the National University of Ireland Galway, said: “From the patient’s perspective, the aim is that you can halt progression of the disease towards end stage kidney disease This is a very exciting development for treatment of this condition.
For more information on the diseases that can be presently treated by umbilical cord stem cells, simply visit: Cord blood and cord tissue stem cell banking